Tandem Diabetes Care Inc (TNDM)

Debt-to-equity ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	285,035	284,580	284,128	283,679	283,232	282,787	282,345	281,905	281,467	281,032	280,599	280,168	202,984	199,120	195,344	—	0	—	—	—
Total stockholders’ equity	US$ in thousands	313,632	314,000	329,234	338,753	439,947	421,822	449,584	437,382	433,112	389,654	346,085	313,414	366,305	326,544	267,704	207,176	194,979	166,994	145,345	120,962
Debt-to-equity ratio		0.91	0.91	0.86	0.84	0.64	0.67	0.63	0.64	0.65	0.72	0.81	0.89	0.55	0.61	0.73	0.00	0.00	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $285,035K ÷ $313,632K
= 0.91

The debt-to-equity ratio for Tandem Diabetes Care Inc has shown a varying trend over the past eight quarters. In the most recent quarter, Q4 2023, the ratio stood at 0.91, which was consistent with the previous quarter, Q3 2023. This indicates that the company's total debt was approximately equal to its total equity during this period.

Looking further back, we observe an increase in the debt-to-equity ratio from Q1 2023 to Q4 2022, reaching a peak of 0.64 in Q4 2022. This suggests an increase in the company's debt relative to its equity during that period. Subsequently, the ratio remained relatively stable around the 0.6 range for the preceding quarters of 2022.

Overall, the trend in Tandem Diabetes Care Inc's debt-to-equity ratio indicates fluctuations in the capital structure of the company over the past two years. Investors and stakeholders may want to monitor this ratio closely to assess the company's leverage and financial risk levels.